Screen for depression
Nanticoke Memorial Hospital’s Behavioral Health program in Seaford will offer free, anonymous Depression Screenings on Oct. 10, from 6:30- 8 p.m. in the Stevens classroom.
The screening is for Depression, Manic Depression, Generalized Anxiety Disorder and Post-Traumatic Stress Disorder. Attendees complete a written screening, discuss the results with a mental-health professional, receive educational materials on depression, and learn the avenues to receiving help.
People suffering from depression often experience a persistent, sad, anxious or empty mood; may sleep too little or too much; may lose interest or pleasure in activities; be restless or irritable; or have difficulty concentrating.
Nanticoke’s Behavioral Health offers a day treatment program for mental health and substance abuse. To learn more about the screening or the day program call 629-2100.
Pink Ribbon Golf Classic
On Wednesday, Sept. 11, 67 women joined the fight against breast cancer. These women came together to listen to Dr. Srihari Peri, medical director, Tunnel Cancer Center, discuss “practical solutions” for reducing a women’s risk of breast cancer.
The event was held at Sussex Pines Country Club in Georgetown, and was coordinated by Christiana Care’s Cancer Prevention Research Office in association with their satellites at the Tunnel Cancer Center at Beebe Medical Center and Nanticoke Memorial Hospital. The event was sponsored by The Delores Springer Pink Ribbon Golf Classic.
For details regarding cancer research trials, contact the Cancer Prevention Research Office at 302-623-4590.
Prostate Cancer Awareness Month
For many years, it has been known as “a man’s disease.” But it doesn’t have to be that way. During Prostate Cancer Awareness Month in September, the Mid-Atlantic Division of the American Cancer Society wants to enlist women in the battle against the second-deadliest cancer striking American men: prostate cancer.
Wives and daughters can be effective allies in the battle against prostate cancer. Women are often the healthcare decision-makers in their families, and play an important role in urging their husbands and fathers to get the important and potentially lifesaving prostate tests.
An estimated 189,000 men in the Untied States will be diagnosed with prostate cancer this year and 32,500 will die of the disease, accounting for 11 percent of all male cancer deaths. In Delaware, a total of 600 men will learn that they have prostate cancer this year, with an estimated 100 dying.
Yet, there is hope for men with prostate cancer. It remains one of the most survivable of all cancers. In the early 1980s, the survival rate from prostate cancer was 67 percent. A generation later, more than 96 percent of men diagnosed with prostate cancer are surviving at least five years. The ten-year survival rate is 75 percent, and 15-year survival rates top 50 percent.
“We’ve made tremendous progress against prostate cancer,” said Charles Leiss, chief executive officer of the American Cancer Society’s Mid-Atlantic Division.
“The American Cancer Society encourages men to discuss their options with their doctors and families. We also invite the women in their lives to help ensure that they get the lifesaving tests.”
The American Cancer Society emphasizes four key points on prostate cancer:
The American Cancer Society has issued guidelines for prostate screening. The guidelines are flexible in order to accommodate individual medical and personal needs, and are subject to revision based on new research evidence. They are:
- Get as much information about prostate health as you can.
- Talk with your doctor to determine your personal risk
- Understand all available testing and treatment options, so you can make an informed decision.
- Contact the American Cancer Society for information about all aspects of prostate cancer 24 hours a day (1-800-ACS-2345 or www.cancer.org).
- Men 50 and older should be offered early detection tests (PSA and DRE) annually.
- Men at high risk (family history, African Americans) should begin early detection testing (PSA and DRE) at age 45.